A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies

Clinical trial NCT06045910 · RECRUITING

Trial details

NCT number: NCT06045910
Sponsor: Cancer Research UK
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Lymphoma, Large B-Cell, Diffuse Lymphoma, Mantle-Cell Lymphoma, Follicular Lymphoma, B-Cell Large B-cell Lymphoma

Start date: 2024-02-07
Primary completion: 2028-02-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.